MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Sezary Syndrome

(UMLS:C0036920)

Definition:: A form of cutaneous T-cell lymphoma manifested by generalized exfoliative ERYTHRODERMA; PRURITUS; peripheral lymphadenopathy, and abnormal hyperchromatic mononuclear (cerebriform) cells in the skin, LYMPH NODES, and peripheral blood (Sezary cells).
UMLS ID:: C0036920
MeSH ID:: D012751

Classification 1:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.386.480.750.800.775

Classification 2:

Name:

Hemic and Lymphatic Diseases
MeSH Tree Number(s):: C15.604.515.569.480.750.800.775|C15.604.515.841

Classification 3:

Name:

Immune System Diseases
MeSH Tree Number(s):: C20.683.515.761.480.750.800.775|C20.683.515.920

Synonym(s)

Sezary Syndrome

CTCL / Sezary syndrome

Cutaneous T-cell lymphoma/Sezary syndrome

RETICULOSIS SYNDROME, SEZARY

Sezary syndrome

Sezary's Disease

Sezary's disease

Sezary's syndrome

S茅zary

10.

S茅zary Syndrome

11.

S茅zary disease

Associated Drug(s)

	Name	Number of Reports	Reference(s)	Data Source
1	Resveratrol		19063842	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Mycosis Fungoides	49.7%
2	Lymphomatoid Papulosis	49.7%
3	Enteropathy-Associated T-Cell Lymphoma	40.7%
4	Tumor Lysis Syndrome	39.8%
5	Lymphoma, Follicular	37.1%
6	Mantle cell lymphoma	37.1%
7	Hodgkin Disease	37%
8	Composite Lymphoma	35.4%
9	Autoimmune Lymphoproliferative Syndrome	35.3%
10	Infectious Mononucleosis	33.2%
11	Heavy Chain Disease	26.5%
12	Lymphoma, AIDS-Related	26.3%
13	Primary Effusion Lymphoma	26.3%
14	Lymphomatoid Granulomatosis	25.2%
15	Leukemia, T-Cell	24.7%
16	Leukemia, B-Cell	24.7%
17	Primary amyloidosis	24.6%
18	Agammaglobulinemia	24.3%
19	Lymphangioleiomyomatosis	23.3%
20	Sarcoidosis	23.1%
21	Plasmacytoma	23%
22	Lymphoma	23%
23	Waldenstrom Macroglobulinemia	22.6%
24	Multiple Myeloma	22.6%
25	Burkitt Lymphoma	21.2%
26	Plasmablastic lymphoma	21%
27	Granuloma	20.1%
28	Sezary Syndrome	19.1%
29	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	18.4%
30	Leukemia, Large Granular Lymphocytic	18.4%
31	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	18.4%
32	Paraproteinemias	17.1%
33	Lymphoma, Non-Hodgkin	17%
34	Adenitis	16.6%
35	Histiocytosis	16.6%
36	Lymphadenitis	16.6%
37	Lymphangitis	16.6%
38	Lymphedema	16.6%
39	Splenic Diseases	16.6%
40	Thymus Hyperplasia	16.6%
41	Pseudolymphoma	16.6%
42	Lymphadenopathy	16.6%
43	Lymphocele	16.4%
44	Monoclonal Gammopathy of Undetermined Significance	16.2%
45	Leukemia, Plasma Cell	15.9%
46	Thymus Neoplasms	15.3%
47	Hypergammaglobulinemia	15.1%
48	Lymphangiectasis, Intestinal	15%
49	Histiocytic Disorders, Malignant	14.6%
50	Lymphatic Abnormalities	14.4%
51	T-Cell Lymphoma	14%
52	Transfusion Reaction	13.6%
53	Hypotensive Transfusion Reaction	13.6%
54	Sarcoidosis, Pulmonary	13.3%
55	Lymphoma, T-Cell, Cutaneous	12.6%
56	Mucocutaneous Lymph Node Syndrome	12.5%
57	Lymphoma, Extranodal NK-T-Cell	12.4%
58	Thymoma	10.7%
59	Splenic Neoplasms	10.6%
60	Autoimmune Diseases	10.1%
61	Hypersensitivity	10.1%
62	Immunologic Deficiency Syndromes	10.1%
63	Immune reconstitution syndrome	10.1%
64	Immune Reconstitution Inflammatory Syndrome	10.1%
65	Elephantiasis	9.9%
66	Hypersplenism	9.9%
67	Elephantiasis Nostras Verrucosa	9.9%
68	Cryoglobulinemia	9.6%
69	Malignant histiocytosis	8.8%
70	Histiocytic sarcoma	8.8%
71	Autoimmune thrombocytopenia	8.7%
72	Immune thrombocytopenic purpura	8.7%
73	Splenic Infarction	8.6%
74	Histiocytosis, Langerhans-Cell	8.5%
75	Thrombocytopenic purpura	8.3%
76	POEMS Syndrome	8.1%
77	Splenic Rupture	7.6%
78	Disseminated Intravascular Coagulation	7.5%
79	Protein S Deficiency	7.5%
80	Glomerulonephritis, Membranoproliferative	7.5%
81	Thrombocythemia, Essential	7%
82	leukemia	6.9%
83	Neoplasms, Germ Cell and Embryonal	6.9%
84	Neoplasms, Glandular and Epithelial	6.9%
85	Germ Cell Cancer	6.9%
86	Hematologic Neoplasms	6.8%
87	Transfusion-Related Acute Lung Injury	6.6%
88	Lymphopenia	6.6%
89	Lymphohistiocytosis, Hemophagocytic	6.6%
90	Schnitzler Syndrome	6.6%
91	Erdheim-Chester Disease	6.6%
92	Neuroectodermal Tumors	6.3%
93	Thrombasthenia	5.9%
94	Antithrombin III Deficiency	5.9%
95	Protein C Deficiency	5.9%
96	Bone Marrow Neoplasms	5.9%
97	Wiskott-Aldrich Syndrome	5.8%
98	Neoplasms, Neuroepithelial	5.8%
99	Gliomatosis cerebri	5.8%
100	Anemia	5.5%
101	Blood Coagulation Disorders	5.5%
102	Blood Platelet Disorders	5.5%
103	Bone Marrow Diseases	5.5%
104	Hemorrhagic Disorders	5.5%
105	Immune Complex Diseases	5.5%
106	Leukocyte Disorders	5.5%
107	Methemoglobinemia	5.5%
108	Pancytopenia	5.5%
109	Polycythemia	5.5%
110	Sulfhemoglobinemia	5.5%
111	Antiphospholipid Syndrome	5.5%
112	Thrombophilia	5.5%
113	Latex allergy	5.5%
114	Erythrocytosis	5.5%
115	Eosinophilic Granuloma	5.4%
116	Hydrops Fetalis	5.3%
117	Afibrinogenemia	5.2%
118	Factor VII Deficiency	5.2%
119	Factor X Deficiency	5.2%
120	Factor XII Deficiency	5.2%
121	Hemophilia A	5.2%
122	Activated Protein C Resistance	5.2%
123	Factor II deficiency	5.2%
124	Factor VIII Deficiency	5.2%
125	Factor V deficiency	5.2%
126	Factor XI Deficiency	5.2%
127	Hypoprothrombinemias	5.2%
128	Meningioma	5.1%
129	Splenosis	5%
130	Vitamin K Deficiency	5%
131	Environmental Illness	4.9%
132	Polycythemia Vera	4.9%
133	Kernicterus	4.9%
134	Carcinosarcoma	4.8%
135	Hemangiosarcoma	4.8%
136	lymphangiosarcoma	4.8%
137	Lupus Erythematosus, Systemic	4.8%
138	Pregnancy Complications, Hematologic	4.8%
139	Overlap syndrome	4.8%
140	Addison Disease	4.7%
141	Pemphigus	4.7%
142	Autoimmune thyroiditis	4.7%
143	Primary Adrenal Insufficiency	4.7%
144	Thrombocytosis	4.7%
145	Job Syndrome	4.7%
146	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	4.7%
147	Autoimmune hepatitis	4.7%
148	Hamartoma	4.6%
149	Neoplasms, Hormone-Dependent	4.6%
150	Neoplasms, Multiple Primary	4.6%
151	Paraneoplastic Syndromes	4.6%
152	Precancerous Conditions	4.6%
153	Neoplasms, Second Primary	4.6%
154	melanoma	4.5%
155	Trophoblastic Neoplasms	4.5%
156	Leukemia, Experimental	4.5%
157	Latent Autoimmune Diabetes in Adults	4.2%
158	Carcinoma 256, Walker	4.2%
159	Chronic granulomatous disease	4.2%
160	Dermatitis Herpetiformis	4.2%
161	Kounis Syndrome	4.2%
162	HIV Infections	4.1%
163	Mastocytosis	4%
164	Leukemia, Radiation-Induced	4%
165	Asthma, Aspirin-Induced	4%
166	Cyst	4%
167	Neoplastic Processes	4%
168	Neoplastic Syndromes, Hereditary	4%
169	Pregnancy Complications, Neoplastic	4%
170	Neoplasms, Experimental	3.9%
171	Purpura, Thrombotic Thrombocytopenic	3.8%
172	Hemoglobinuria, Paroxysmal	3.8%
173	Leukemoid Reaction	3.8%
174	Carcinoma, Ehrlich Tumor	3.7%
175	Dermoid Cyst	3.7%
176	Carcinoma, Lewis Lung	3.7%
177	Rheumatoid Arthritis	3.7%
178	Juvenile arthritis	3.7%
179	Anemia, Diamond-Blackfan	3.7%
180	Graves Disease	3.7%
181	Serum Sickness	3.7%
182	Anti-Glomerular Basement Membrane Disease	3.7%
183	Adenoma	3.6%
184	Ameloblastoma	3.6%
185	Angiokeratoma	3.6%
186	Carcinoma	3.6%
187	Chordoma	3.6%
188	Hemangioma	3.6%
189	hemangiopericytoma	3.6%
190	Lymphangioma	3.6%
191	Mesenchymoma	3.6%
192	Nevus	3.6%
193	Teratoma	3.6%
194	Hepatoblastoma	3.6%
195	Mixed Tumor, Mullerian	3.6%
196	Germinoma	3.6%
197	Teratocarcinoma	3.6%
198	Angiofibroma	3.6%
199	Sarcoma	3.6%
200	Epithelioma	3.6%
201	Leukemia, Myelomonocytic, Chronic	3.6%
202	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	3.6%
203	Multiple Endocrine Neoplasia	3.6%
204	Melanoma, Experimental	3.6%
205	Neoplasms, Radiation-Induced	3.5%
206	Basal cell carcinoma	3.4%
207	Carcinoma, Papillary	3.4%
208	Squamous cell carcinoma	3.4%
209	Chondrosarcoma	3.4%
210	Craniopharyngioma	3.4%
211	Cystadenoma	3.4%
212	leiomyosarcoma	3.4%
213	liposarcoma	3.4%
214	Mesothelioma	3.4%
215	synovial sarcoma	3.4%
216	Neuroectodermal Tumor, Melanotic	3.4%
217	Angiomyolipoma	3.4%
218	Clear Cell Sarcoma of Soft Tissue	3.4%
219	Alveolar Soft Part Sarcoma	3.4%
220	Neuroendocrine Tumors	3.4%
221	Sarcoma, Myeloid	3.4%
222	Carcinoma, Basal Cell	3.4%
223	Anemia, Sickle Cell	3.3%
224	Thalassemia	3.3%
225	Adenoma, Acidophil	3.3%
226	Ganglioneuroma	3.3%
227	Glioma	3.3%
228	Malignant Glioma	3.3%
229	anaphylaxis	3.3%
230	Anemia, Hemolytic	3.3%
231	Anemia, Macrocytic	3.3%
232	Eosinophilia	3.3%
233	Food Allergy	3.3%
234	Hypoproteinemia	3.3%
235	Leukopenia	3.3%
236	Thrombocytopenia	3.3%
237	Leukostasis	3.3%
238	MYELODYSPLASTIC SYNDROME	3.3%
239	Anaphylactic shock	3.3%
240	Sarcoma, Experimental	3.3%
241	Endometrial Stromal Sarcoma	3.2%
242	Hemangioma, Cavernous	3.2%
243	Medulloblastoma	3%
244	Tuberous Sclerosis	3%
245	Choriocarcinoma	3%
246	Carcinoma, Lobular	3%
247	Nephroblastoma	2.9%
248	Mastocytosis, Systemic	2.9%
249	Respiratory Hypersensitivity	2.9%
250	Lambert-Eaton Myasthenic Syndrome	2.9%
251	Anemia, Neonatal	2.9%
252	Leukocytosis	2.9%
253	Pelger-Huet Anomaly	2.9%
254	Sick Building Syndrome	2.9%
255	Pleocytosis	2.9%
256	Multiple Chemical Sensitivity	2.9%
257	Urticaria	2.8%
258	Vasculitis, Leukocytoclastic, Cutaneous	2.8%
259	HTLV-I Infections	2.8%
260	Ataxia Telangiectasia	2.8%
261	Leukemia L1210	2.8%
262	Leukemia P388	2.8%
263	Acanthoma	2.8%
264	Cystadenocarcinoma	2.8%
265	Fibrosarcoma	2.8%
266	Osteosarcoma	2.8%
267	Mucoepidermoid Carcinoma	2.8%
268	Carcinoid Tumor	2.7%
269	Neurilemmoma	2.7%
270	Hutchinson's Melanotic Freckle	2.7%
271	Melanoma, Amelanotic	2.7%
272	Paraneoplastic Encephalomyelitis	2.7%
273	Purpura, Hyperglobulinemic	2.7%
274	Mammary Neoplasms, Experimental	2.7%
275	Hemolytic-Uremic Syndrome	2.6%
276	Retinoblastoma	2.6%
277	Myasthenia Gravis	2.5%
278	Uveomeningoencephalitic Syndrome	2.5%
279	Drug Eruptions	2.5%
280	Ecchymosis	2.5%
281	Petechiae	2.5%
282	Purpura	2.5%
283	Granulomatosis with polyangiitis	2.5%
284	Dermatitis, Allergic Contact	2.5%
285	HIV Seropositivity	2.5%
286	Leukemia, Myeloid, Chronic-Phase	2.5%
287	Myasthenia Gravis, Autoimmune, Experimental	2.4%
288	Sickle Cell Trait	2.4%
289	Adenofibroma	2.4%
290	Fibroadenoma	2.4%
291	Malignant Fibrous Histiocytoma	2.4%
292	Waterhouse-Friderichsen Syndrome	2.4%
293	Abdominal Neoplasms	2.3%
294	Erythroplasia	2.3%
295	Follicular cyst	2.3%
296	Head and Neck Neoplasms	2.3%
297	Mucocele	2.3%
298	Pilonidal Cyst	2.3%
299	Soft Tissue Neoplasms	2.3%
300	Thoracic Neoplasms	2.3%
301	Thyroglossal Cyst	2.3%
302	Synovial Cyst	2.3%
303	Aberrant Crypt Foci	2.3%
304	Stiff-Person Syndrome	2.3%
305	Polyradiculoneuropathy	2.2%
306	Polyradiculoneuritis	2.2%
307	Fanconi Anemia	2.2%
308	Acquired Immunodeficiency Syndrome	2.2%
309	AIDS related complex	2.2%
310	Primary Myelofibrosis	2.2%
311	Agranulocytosis	2.2%
312	Anemia, Megaloblastic	2.2%
313	Lymphocytosis	2.2%
314	Myelofibrosis	2.2%
315	Myeloid Metaplasia	2.2%
316	Milk Allergy	2.2%
317	Hypoalbuminemia	2.2%
318	Wheat Hypersensitivity	2.2%
319	Hypereosinophilic syndrome	2.2%
320	bone marrow fibrosis	2.2%
321	Thrombotic Microangiopathies	2.2%
322	Basal Cell Nevus Syndrome	2.2%
323	Felty Syndrome	2.2%
324	Lupus Nephritis	2.2%
325	Mesoblastic Nephroma	2.2%
326	Astrocytoma	2.1%
327	Ependymoma	2.1%
328	oligodendroglioma	2.1%
329	Ganglioglioma	2.1%
330	gliosarcoma	2.1%
331	Anaplastic astrocytoma	2.1%
332	Anaplastic Oligodendroglioma	2.1%
333	Sarcoma 180	2.1%
334	Lupus Vasculitis, Central Nervous System	2.1%
335	Bowen's Disease	2.1%
336	Paraganglioma	2.1%
337	Rhabdomyosarcoma	2.1%
338	Giant Cell Tumor of Bone	2.1%
339	Digestive System Neoplasms	2%
340	Endocrine Gland Neoplasms	2%
341	Eye Neoplasms	2%
342	Nervous System Neoplasms	2%
343	Atypical Hemolytic Uremic Syndrome	2%
344	AIDS-Related Opportunistic Infections	2%
345	Vasculitis, Central Nervous System	2%
346	Adenocarcinoma	2%
347	Carcinoma in Situ	2%
348	Carcinoma, Transitional Cell	2%
349	Phyllodes Tumor	2%
350	Dysgerminoma	2%
351	Hemangioendothelioma	2%
352	Lipoma	2%
353	Myoma	2%
354	Myxoma	2%
355	Neuroma	2%
356	Papilloma	2%
357	Pseudomyxoma Peritonei	2%
358	Seminoma	2%
359	Papillomatosis	2%
360	Angiolipoma	2%
361	Myelolipoma	2%
362	Neoplasms, Bone Tissue	2%
363	Neoplasms, Fibrous Tissue	2%
364	Smooth Muscle Tumor	2%
365	Adenomatosis, Pulmonary	2%
366	Adenomatous Polyps	2%
367	Carcinoma, Large Cell	2%
368	Carcinoma, Small Cell	2%
369	Desmoplastic Small Round Cell Tumor	2%
370	Chondroma	2%
371	Enchondroma	2%
372	Bone neoplasms	2%
373	Leukoplakia	2%
374	Pancreatic Cyst	2%
375	Skin Neoplasms	2%
376	Acute Chest Syndrome	2%
377	Dermatitis, Atopic	2%
378	Barrett Esophagus	2%
379	Breast Cyst	2%
380	Actinic keratosis	2%
381	Mediastinal Cyst	2%
382	Neoplasm Invasiveness	2%
383	Neoplasm Metastasis	2%
384	Neoplasm Recurrence, Local	2%
385	Parovarian Cyst	2%
386	Pericardial Cyst	2%
387	Thymic Cyst	2%
388	Carcinogenesis	2%
389	Myxoid cyst	2%
390	Metastasis	2%
391	HIV Wasting Syndrome	2%
392	Rheumatoid Vasculitis	2%
393	AIDS Dementia Complex	2%
394	AIDS-Associated Nephropathy	2%
395	Niemann-Pick Disease, Type C	2%
396	Neurofibrosarcoma	1.9%
397	Myelitis, Transverse	1.9%
398	Multiple Endocrine Neoplasia Type 1	1.9%
399	Sicca Syndrome	1.8%
400	Sjogren's Syndrome	1.8%
401	Neuromyelitis Optica	1.8%
402	Hepatocellular Adenoma	1.8%
403	Liver Neoplasms, Experimental	1.8%
404	Leukoencephalitis, Acute Hemorrhagic	1.8%
405	HIV-Associated Lipodystrophy Syndrome	1.8%
406	Malignant Carcinoid Syndrome	1.8%
407	Corpus Luteum Cyst	1.7%
408	Ovarian Cysts	1.7%
409	Dermatofibrosarcoma	1.7%
410	Dermatofibrosarcoma Protuberans	1.7%
411	Eosinophilia-Myalgia Syndrome	1.7%
412	Carcinoma, Pancreatic Ductal	1.7%
413	Angioedema	1.7%
414	Multiple Sclerosis	1.7%
415	Shwartzman Phenomenon	1.7%
416	Neutropenia	1.7%
417	Scurvy	1.7%
418	Purpura Fulminans	1.7%
419	Acute Generalized Exanthematous Pustulosis	1.7%
420	Parathyroid Neoplasms	1.7%
421	Peritoneal Neoplasms	1.7%
422	Thyroid Neoplasm	1.7%
423	Thyroid carcinoma	1.7%
424	Prolactinoma	1.6%
425	Growth Hormone-Secreting Pituitary Adenoma	1.6%
426	Adenomatous Polyposis Coli	1.6%
427	Choledochal Cyst	1.6%
428	Peutz-Jeghers Syndrome	1.5%
429	Sturge-Weber Syndrome	1.5%
430	Gastrointestinal Stromal Tumors	1.5%
431	Asthma	1.5%
432	neurofibroma	1.5%
433	Acoustic Neuroma	1.5%
434	Pancreatic Neoplasm	1.5%
435	Glioblastoma	1.5%
436	Neuroblastoma	1.5%
437	Glioblastoma Multiforme	1.5%
438	Encephalomyelitis, Acute Disseminated	1.5%
439	Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	1.5%
440	Erythema Nodosum	1.5%
441	Neuritis, Autoimmune, Experimental	1.5%
442	Dermatitis, Photoallergic	1.5%
443	granulosa cell tumor	1.5%
444	Carcinoma, Ovarian Epithelial	1.5%
445	Pulmonary Eosinophilia	1.5%
446	Eosinophilic Pneumonia	1.5%
447	Anemia, Pernicious	1.4%
448	Hydatidiform Mole	1.4%
449	Febrile Neutropenia	1.4%
450	Optic Nerve Glioma	1.4%
451	Pheochromocytoma	1.4%
452	Alveolar rhabdomyosarcoma	1.4%
453	Aspergillosis, Allergic Bronchopulmonary	1.3%
454	Guillain-Barre Syndrome	1.3%
455	Tracheal Neoplasms	1.3%
456	Leukoplakia, Oral	1.3%
457	Asthma, Exercise-Induced	1.3%
458	Status Asthmaticus	1.3%
459	Paraneoplastic Cerebellar Degeneration	1.3%
460	Multiple Sclerosis, Chronic Progressive	1.3%
461	Multiple Sclerosis, Relapsing-Remitting	1.3%
462	Denys-Drash Syndrome	1.2%
463	Retroperitoneal Neoplasms	1.2%
464	Toxic Epidermal Necrolysis	1.2%
465	Stevens-Johnson Syndrome	1.2%
466	Carcinoid Heart Disease	1.2%
467	Adenoid Cystic Carcinoma	1.2%
468	fibroma	1.2%
469	Fibromatosis	1.2%
470	Osteoblastoma	1.2%
471	Osteoma	1.2%
472	Rhabdomyoma	1.2%
473	Chondromatosis	1.2%
474	Adenocarcinoma, Clear Cell	1.2%
475	Cholangiocarcinoma	1.2%
476	Cervical Intraepithelial Neoplasia	1.2%
477	Hemangioblastoma	1.2%
478	Vipoma	1.2%
479	Ganglioneuroblastoma	1.2%
480	Asthma, Occupational	1.2%
481	Esophageal Neoplasms	1.1%
482	Nasopharyngeal carcinoma	1.1%
483	Limbic Encephalitis	1.1%
484	Farmer's Lung	1.1%
485	Pseudoxanthoma Elasticum	1.1%
486	Angioedemas, Hereditary	1.1%
487	Hay fever	1.1%
488	Rhinitis, Allergic, Perennial	1.1%
489	Giant Cell Arteritis	1.1%
490	Temporal Arteritis	1.1%
491	insulinoma	1.1%
492	Xeroderma Pigmentosum	1.1%
493	Mouth Neoplasms	1.1%
494	Central Nervous System Neoplasms	1.1%
495	Vascular Neoplasms	1.1%
496	Hereditary Angioedema Type III	1.1%
497	Hereditary Angioedema Types I and II	1.1%
498	Testicular Neoplasms	1%
499	Genital Neoplasms, Female	1%
500	Pancreatic Pseudocyst	1%
501	Lymphatic Metastasis	1%
502	Neoplasms, Unknown Primary	1%
503	Leukemic Infiltration	1%
504	Breast Neoplasms, Male	1%
505	Neoplasm Micrometastasis	1%
506	Triple Negative Breast Neoplasms	1%
507	Mastocytoma	1%
508	Adrenocortical carcinoma	1%
509	Opsoclonus-Myoclonus Syndrome	1%
510	Adrenal Gland Neoplasms	0.9%
511	Gastrointestinal Neoplasms	0.9%
512	Genital Neoplasms, Male	0.9%
513	Liver neoplasms	0.9%
514	Uveal Neoplasms	0.9%
515	Leydig Cell Tumor	0.9%
516	Urologic Neoplasms	0.9%
517	Sebaceous Gland Neoplasms	0.9%
518	Spinal Neoplasms	0.9%
519	Polycystic Ovary Syndrome	0.9%
520	Thyroid Nodule	0.9%
521	Gastrinoma	0.9%
522	Glucagonoma	0.9%
523	Renal Cell Carcinoma	0.9%
524	Papillary Renal Cell Carcinoma	0.9%
525	Fibromatosis, Aggressive	0.8%
526	Fibromatosis, Abdominal	0.8%
527	Klatskin Tumor	0.8%
528	Carcinoma, Endometrioid	0.8%
529	Miller Fisher Syndrome	0.8%
530	ovarian neoplasm	0.7%
531	Nose Neoplasms	0.7%
532	Pituitary Adenoma	0.7%
533	Pituitary Neoplasms	0.7%
534	Dupuytren Contracture	0.6%
535	Zollinger-Ellison syndrome	0.6%
536	Urticaria Pigmentosa	0.6%
537	Palatal Neoplasms	0.6%
538	Meningeal Neoplasms	0.6%
539	Ear Neoplasms	0.5%
540	Eyelid Neoplasms	0.5%
541	Lung Neoplasms	0.5%
542	Pleural Neoplasms	0.5%
543	Cell Transformation, Viral	0.5%
544	Brain Neoplasms	0.5%
545	Salivary Gland Neoplasms	0.5%
546	Spinal Cord Neoplasms	0.5%
547	Tongue Neoplasms	0.5%
548	Uterine Neoplasms	0.5%
549	Vaginal Neoplasms	0.5%
550	Vulvar Neoplasms	0.5%
551	Uterine Cancer	0.5%
552	Fallopian Tube Neoplasms	0.5%
553	Pharyngeal Neoplasms	0.5%
554	Central Nervous System Cysts	0.5%
555	Bile Duct Neoplasms	0.5%
556	gallbladder neoplasm	0.5%
557	Intestinal Neoplasms	0.5%
558	Penile Neoplasms	0.5%
559	Prostatic Neoplasms	0.5%
560	Stomach Neoplasms	0.5%
561	Laryngeal neoplasm	0.4%
562	Bladder Neoplasm	0.4%
563	Kidney Neoplasm	0.4%
564	Ureteral Neoplasms	0.4%
565	Urethral Neoplasms	0.4%
566	Meningeal Carcinomatosis	0.3%
567	Bronchial Neoplasms	0.3%
568	Multiple Pulmonary Nodules	0.3%
569	Supratentorial Neoplasms	0.3%
570	Endometrial Neoplasms	0.3%
571	Hypopharyngeal Neoplasms	0.3%
572	Pleural Effusion, Malignant	0.3%
573	Hypopharyngeal Cancer	0.3%
574	Parotid Neoplasms	0.3%
575	Prostatic Neoplasms, Castration-Resistant	0.3%
576	Nelson Syndrome	0.3%
577	Cecal Neoplasms	0.2%
578	Duodenal Neoplasms	0.2%
579	Nasopharyngeal Neoplasms	0.2%
580	Colorectal Neoplasms	0.2%
581	Paranasal Sinus Neoplasms	0.2%
582	Brain Stem Neoplasms	0.2%
583	Tonsillar Neoplasms	0.2%
584	Cerebellar Neoplasms	0.2%
585	Radicular Cyst	0.2%
586	Appendiceal Neoplasms	0.2%
587	Colonic Neoplasms	0.2%
588	Rectal Neoplasms	0.2%
589	Choroid Plexus Papilloma	0.1%
590	Maxillary Sinus Neoplasms	0.1%
591	Anus Neoplasms	0.1%
592	Sigmoid Neoplasms	0.1%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234